× Medicines Discovery Catapult

It can take 10-15 years to develop a new medicine at an estimated cost of £1.2bn

At the Medicines Discovery Catapult we aim to help UK SME biotechs, academics and innovators have access to the laboratory facilities, knowledge, data, technologies and networks they need to be able to progress their programmes of medicines research and development. Our objective is to work collaboratively as part of a Syndicate to bring new proven therapies to patients faster and more cost-effectively.

Latest News

Bringing the benefits of cutting-edge mass spectrometry technologies to UK SMEs

Medicines Discovery Catapult and Waters partner to support UK medicines discovery with advanced technology solutions Today (12th June 2019), Medicines Discovery Catapult announce the launch

New report unveils a thriving service and supply sector for UK medicines discovery

Driving innovation into state-of-the-art technologies such as Artificial Intelligence and Complex Cell Models is key to maintaining the UK’s global competitiveness Today (13th May 2019),

Medicines Discovery Catapult and LifeArc launch strategic R&D partnerships in biomarker discovery and proteomics technology

Today (9th May 2019), Medicines Discovery Catapult and LifeArc, leading forces driving UK innovation in drug discovery, announce their strategic partnership. The identification and development

All News >